Schuth Alexander O.
SEC CIK 1724311 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | COO, Sec | 279.0K | — | $7.93M | 51 | 2021-07-06 | 2026-09-01 |
Most active insiders at DNLI, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Watts Ryan J. | Pres, CEO, Dir | — | $580.8K |
| 2 | Schuth Alexander O. | COFO, Sec | — | $420.6K |
| 3 | Thornberry Nancy | Dir | — | $261.9K |
| 4 | Chin Peter Scott | Chief Medical Off | — | $36.9K |
| 5 | Van Hauwermeiren Timothy | Dir | — | — |
| 6 | Cook Jennifer E. | Dir | — | — |
| 7 | Krognes Steve E. | Dir | — | — |
| 8 | Schenkein David P | Dir | — | — |
| 9 | Klein Peter S | Dir | — | — |
| 10 | BAKER BROS. ADVISORS LP | Dir | — | — |
Transactions 51
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-03 16:17 | 2026-09-01 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $23.44 | -2,768 | 279.0K | -1.0% | -$64.9K |
| 2026-08-13 17:01 | 2026-08-11 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $25.07 | -2,857 | 281.8K | -1% | -$71.6K | |
| 2026-01-08 | 2026-01-06 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $16.50 | -17.2K | 282.8K | -6% | -$284.1K | |
| D | 2026-01-05 | 2026-01-03 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | A - Grant | $0.00 | +57.7K | 300.0K | +24% | $0 |
| 2025-08-14 | 2025-08-12 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $13.58 | -2,937 | 242.3K | -1% | -$39.9K | |
| M | 2025-01-08 | 2025-01-06+ | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $20.33 | -15.2K | 244.3K | -6% | -$308.3K |
| D | 2025-01-07 | 2025-01-03 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | A - Grant | $0.00 | +54.2K | 259.5K | +26% | $0 |
| D | 2024-12-31 | 2024-12-27 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $5.28 | +6,708 | 205.3K | +3% | +$35.4K |
| D | 2024-11-26 | 2024-11-22 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $0.68 | +20.5K | 198.6K | +12% | +$14.0K |
| DM | 2024-11-12 | 2024-11-07 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale+OE | $29.91 | -15.6K | 178.1K | -8% | -$465.3K |
| D | 2024-11-12 | 2024-11-07 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $5.28 | +15.6K | 193.6K | +9% | +$82.1K |
| M | 2024-08-22 | 2024-08-20+ | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $23.99 | -8,353 | 184.0K | -4% | -$200.4K |
| 2024-08-15 | 2024-08-13 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $22.89 | -2,272 | 186.4K | -1% | -$52.0K | |
| M | 2024-02-15 | 2024-02-13+ | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $17.62 | -22.8K | 187.3K | -11% | -$402.4K |
| D | 2024-02-12 | 2024-02-08 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $0.68 | +50.0K | 210.2K | +31% | +$34.0K |
| I | 2024-01-09 | 2024-01-05 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $19.43 | -9,972 | 539.3K | -2% | -$193.8K |
| D | 2024-01-05 | 2024-01-03 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | A - Grant | $0.00 | +53.7K | 170.2K | +46% | $0 |
| I | 2023-08-25 | 2023-08-23 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $23.17 | -2,522 | 519.0K | -0.5% | -$58.4K |
| I | 2023-08-23 | 2023-08-21 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $22.59 | -2,478 | 521.5K | -0.5% | -$56.0K |
| I | 2023-08-16 | 2023-08-14 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $23.67 | -2,772 | 519.0K | -0.5% | -$65.6K |
| I | 2023-08-14 | 2023-08-10 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $24.18 | -2,853 | 521.8K | -0.5% | -$69.0K |
| DMI | 2023-07-19 | 2023-07-17+ | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale+OE | $29.80 | -19.7K | 528.7K | -4% | -$587.2K |
| DI | 2023-07-19 | 2023-07-17 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $5.28 | +10.0K | 538.7K | +2% | +$52.8K |
| DI | 2023-05-17 | 2023-05-15 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $5.28 | +10.0K | 538.7K | +2% | +$52.8K |
| DMI | 2023-05-17 | 2023-05-15 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale+OE | $28.60 | -10.0K | 528.7K | -2% | -$286.0K |
| DMI | 2023-04-14 | 2023-04-12+ | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $5.28 | +10.0K | 533.8K | +2% | +$52.8K |
| DMI | 2023-04-14 | 2023-04-12+ | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale+OE | $25.04 | -10.0K | 528.7K | -2% | -$250.4K |
| DI | 2023-02-15 | 2023-02-13 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale+OE | $30.09 | -3,497 | 528.7K | -0.7% | -$105.2K |
| DI | 2023-02-15 | 2023-02-13 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $0.68 | +25.0K | 524.9K | +5% | +$17.0K |
| I | 2023-02-10 | 2023-02-08 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $30.89 | -1,521 | 499.9K | -0.3% | -$47.0K |
| DI | 2023-01-19 | 2023-01-17 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $5.28 | +10.0K | 507.2K | +2% | +$52.8K |
| DMI | 2023-01-19 | 2023-01-17 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale+OE | $29.53 | -10.0K | 497.3K | -2% | -$295.3K |
| I | 2023-01-09 | 2023-01-05 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $28.44 | -2,636 | 497.2K | -0.5% | -$75.0K |
| AI | 2023-01-09 | 2023-01-04 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $28.70 | -2,912 | 492.3K | -0.6% | -$83.6K |
| D | 2023-01-05 | 2023-01-03 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | A - Grant | $0.00 | +41.1K | 157.6K | +35% | $0 |
| D | 2023-01-05 | 2023-01-04 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $28.70 | -2,912 | 149.8K | -2% | -$83.6K |
| DI | 2022-10-12 | 2022-10-07 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | M - OptEx | $0.68 | +20.0K | 487.5K | +4% | +$13.6K |
| I | 2022-08-23 | 2022-08-19 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | S - Sale | $33.22 | -2,576 | 467.5K | -0.5% | -$85.6K |
| 2022-08-11 | 2022-08-09 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COFO, Sec | A - Grant | $0.00 | +22.5K | 121.5K | +23% | $0 | |
| I | 2022-02-15 | 2022-02-11 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $34.68 | -2,803 | 465.0K | -0.6% | -$97.2K |
| I | 2022-02-11 | 2022-02-09 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $37.10 | -1,423 | 460.6K | -0.3% | -$52.8K |
| I | 2022-01-07 | 2022-01-05 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $44.77 | -2,846 | 457.7K | -0.6% | -$127.4K |
| D | 2022-01-05 | 2022-01-03 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | A - Grant | $0.00 | +31.0K | 117.5K | +36% | $0 |
| MI | 2021-12-08 | 2021-12-06 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $42.27 | -10.0K | 460.3K | -2% | -$422.7K |
| MI | 2021-11-08 | 2021-11-04 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $52.84 | -10.0K | 466.4K | -2% | -$528.4K |
| MI | 2021-10-06 | 2021-10-04 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $50.56 | -10.0K | 477.1K | -2% | -$505.6K |
| D | 2021-09-22 | 2021-09-20 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | M - OptEx | $0.68 | +9,045 | 95.5K | +10% | +$6,151 |
| MI | 2021-09-09 | 2021-09-07 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $55.55 | -10.0K | 474.0K | -2% | -$555.5K |
| MI | 2021-08-23 | 2021-08-19 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $49.60 | -2,544 | 484.0K | -0.5% | -$126.2K |
| MI | 2021-08-06 | 2021-08-04 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $52.22 | -10.0K | 490.0K | -2% | -$522.2K |
| I | 2021-07-08 | 2021-07-06 | DNLI | Denali Therapeutics Inc. | Schuth Alexander O. | COO, Sec | S - Sale | $76.20 | -10.0K | 491.6K | -2% | -$762.0K |
Purchase Sale Sale after option exercise All abbreviations